Cutaneous manifestations secondary to the COVID-19 pandemic. Case presentation
Keywords:
COVID-19, coronavirus, pandemic, herpes simplex, alopecia areata.Abstract
Introduction: The primary cutaneous manifestations of SARS-CoV-2 infection are grouped into five clinical dermatologic patterns. However, the implications of the COVID-19 pandemic in terms of skin conditions also include a worsening of pre-existing skin diseases, an increase in the incidence of stress-related dermatoses and others related to physical-chemical factors.
Objective: To present a patient with ocular herpes simplex and alopecia areata of the beard as secondary cutaneous manifestations to the COVID-19 pandemic.
Case presentation: Twenty-two-year-old male patient, medical student, with personal pathological history of apparent health who is conducting the active investigation of respiratory symptoms in support of the confrontation with COVID-19. Primary ocular infection with herpes simplex virus type 1 with recurrence 15 days later as well as alopecia areata of the beard in single plaque were diagnosed approximately 8 weeks after the first case of COVID-19 was diagnosed in Cuba.
Conclusions: Herpes simplex and alopecia areata are skin manifestations secondary to the COVID-19 pandemic. The changes in lifestyle that this disease has caused may be the triggering factor for these stress-related dermatoses to which health care personnel are more vulnerable than the rest of the population.
Downloads
References
1.Arias Molina Y, Herrero Solano Y, Cabrera Hernández Y, Chibás Guyat D, García Mederos Y. Manifestaciones psicológicas frente a la situación epidemiológica causada por la COVID-19. Rev haban cienc méd [Internet]. 2020 [Citado 04/09/2020];19(Supl.):e3350. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3350
2. Candelaria Brito JC, Díaz Cruz SA, Acosta Pérez DM, Labrador Mazón O, Rodríguez Méndez A. Estrategia intervencionista dirigida a la prevención y control de la COVID-19 en Consolación del Sur. Rev Ciencias Médicas [Internet]. 2020 [Citado 04/09/2020];24(3):e4495. Disponible en: http://revcmpinar.sld.cu/index.php/publicaciones/article/view/4495
3. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. Geneva: World Health Organization; 2020 [Citado 10/09/2020]. Disponible en: https://www.who.int/publications-detail/clinicalmanagement-of-severe-acute-respiratory-infectionwhen-novel-coronavirus-(ncov)-infection-issuspected
4. Centro Nacional de Información de Ciencias Médicas. Infecciones por coronavirus. Nota informativa sobre la COVID-19 en Cuba: 10 de septiembre [Internet]. La Habana: Centro Nacional de Información de Ciencias Médicas; 2020 [Citado 10/09/2020]. Disponible en: https://temas.sld.cu/coronavirus/2020/09/11/nota-informativa-sobre-la-covid-19-en-cuba-10-de-septiembre/
5. Pérez Abreu MR, Gómez Tejeda JJ, Diéguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev haban cienc méd [Internet]. 2020 [Citado 04/09/2020];19(2):e_3254. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505
6. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol [Internet]. 2020 [Citado 04/09/2020];34(5):e212. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16387
7. Galván Casas C, Català A, Carretero Hernández G, Rodríguez Jiménez P, Fernández Nieto D, Rodríguez Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology [Internet]. 2020 [Citado 04/09/2020];183(1):71-7. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/bjd.19163
8. Almutairi N, Schwartz RA. COVID-19 with dermatologic manifestations and implications: An unfolding conundrum. Dermatologic Therapy [Internet]. 2020 [Citado 04/09/2020];e13544. Disponible en: https://doi.org/10.1111/dth.13544
9. Hernández Rodríguez J. Impacto de la COVID-19 sobre la salud mental de las personas. Medicentro Electrónica [Internet]. 2020 [Citado 04/09/2020];24(3):[Aprox. 16 p.]. Disponible en: http://www.medicentro.sld.cu/index.php/medicentro/article/view/3203
10. Proenza Fernández L, Gallardo Sánchez Y, Figueredo Remón RJ. Caracterización del comportamiento académico en estudiantes de medicina frente a la pesquisa de la COVID-19. Multimed [Internet]. 2020 [Citado 05/09/2020];24(3):599-615. Disponible en: http://www.revmultimed.sld.cu/index.php/mtm/article/view/1949/1954
11. Pérez Abreu MR, Gómez Tejeda JJ, Tamayo Velázquez O, Iparraguirre Tamayo AE, Besteiro Arjona ED. Alteraciones psicológicas en estudiantes de medicina durante la pesquisa activa de la COVID-19. MEDISAN [Internet]. 2020 [Citado 05/09/2020];24(4):[Aprox. 11 p.]. Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/3159
12. Turan Ç, Metin N, Utlu Z, Öner Ü, Kotan ÖS. Change of the diagnostic distribution in applicants to dermatology after COVID-19 pandemic: What it whispers to us?. Dermatologic Therapy [Internet]. 2020 [Citado 05/09/2020];33(4):e13804. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/dth.13804
13. Irarragorri Dorado CA, Masó Semanat E, Rodríguez Alonso Y, del Valle Caballero Dd. Caracterización epidemiológica y clínica de pacientes con infecciones oculares causadas por herpesvirus. MEDISAN [Internet]. 2020 [Citado 05/09/2020];24(1):[Aprox. 14 p.]. Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/2593
14. González Pérez Y, Falcón Lincheta L. Calidad de vida pre y post tratamiento en pacientes con herpes simple. Folia Dermatológica Cubana [Internet]. 2018 [Citado 05/09/2020];12(1):e113. Disponible en: http://www.revfdc.sld.cu/index.php/fdc/article/view/113/94
15. Sánchez Segura M, González García RM, Cos Padrón Y, Macías Abraham C. Estrés y sistema inmune. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2007 [Citado 05/09/2020];23(2):[Aprox. 2 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892007000200001&lng=es.
16. Metola Gómez M, Camacho Pastor MA, Dones Carvajal JJ, Martín Blázquez M. Alopecia areata: ¿desencadenante el estrés?. SEMERGEN. 2004; 30(2):87-9.
17. González Hernández WC, Méndez Juárez A, Sánchez Álvarez I. Tratamientos emergentes de la alopecia areata. Dermatol Rev Mex [Internet]. 2019 [Citado 05/09/2020];63(5):469-80. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd-2019/rmd195f.pdf
18. Morales Miranda AY, Bueno Arias GM, Aguirre Félix OG, Tovar Franco R. Tratamiento con tofacitinib en adolescentes con alopecia areata. Bol Med Hosp Infant Mex [Internet]. 2019 [Citado 05/09/2020];76:182-7. Disponible en: https://www.medigraphic.com/pdfs/bmhim/hi-2019/hi194d.pdf
Download PDF
